Anti-arthritic agents--SMi conference: trapping cytokines. 28-29 April 2003, London, UK.
Evans
Ruth
R
Thomson Current Drugs, London, UK. ruth.evans@current-drugs.com
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000378:metabolism; D001241:Aspirin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D016207:Cytokines / Q000037:antagonists & inhibitors; D006801:Humans; D020928:Mitogen-Activated Protein Kinases / Q000037:antagonists & inhibitors; D009281:Naphthalenes / Q000627:therapeutic use; D011239:Prednisolone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D011720:Pyrazoles / Q000627:therapeutic use; D048051:p38 Mitogen-Activated Protein Kinases; D010671:Phenylurea Compounds
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D018501:Antirheumatic Agents; D001241:Aspirin; D016207:Cytokines; D020928:Mitogen-Activated Protein Kinases; D009281:Naphthalenes; D011239:Prednisolone; D011720:Pyrazoles; D048051:p38 Mitogen-Activated Protein Kinases; C418962:prednisolone 21-((4'-nitrooxymethyl)benzoate); C102148:nitroaspirin; C452139:doramapimod; D010671:Phenylurea Compounds